By Editor , 4 November 2026
Cardiol Opens US$75M ATM Program With Jefferies for Heart Drugs

TORONTO – November 03, 2026 -- Cardiol Therapeutics Inc. (NASDAQ: CRDL; TSX: CRDL) has entered into an at-the-market program that lets it sell up to US$75 million of common shares through Jefferies LLC to fund late-stage cardiac drug development.

Cardiol restricts ATM share sales to U.S. trading venues

Shares will be sold in ordinary brokers' transactions on the Nasdaq Capital Market or other U.S. trading markets at prevailing market prices. No shares will be sold through the Toronto Stock Exchange or elsewhere in Canada.

By Editor , 4 November 2026
Curaleaf Q3 Revenue Hits Record $352.7M as International Jumps 28%

STAMFORD – November 03, 2026 -- Curaleaf Holdings reported record third-quarter net revenue of $352.7 million, up 10.9% from $317.9 million a year earlier, as its international segment grew 28% and its domestic business grew 8%. Sequentially, revenue rose 3.6% from $340.1 million in the second quarter of 2026.

By Editor , 4 November 2026
FAST Platforms Shift to Pause Ads and Direct Sales as CPMs Fall

Montreal – November 03, 2026 -- FAST platforms can no longer rely on the traditional 30-second pre-roll, and executives from Xumo, LG and Equativ say pause ads, shorter spots and direct sales are the way to protect CPMs. The panel, moderated by Stingray Chief Revenue Officer David Purdy at TVOT Montreal 2026, focused on raising revenue per hour without driving viewers away.

By Editor , 4 November 2026
OCIANA Completes Key Port Call Platform Validation Phase

Montreal – November 03, 2026 -- OCIANA has completed a key phase of Operational Validation Testing (OVT) for its unified port call platform, with four Canadian maritime partners confirming that ship operators and port stakeholders can schedule vessel arrivals on a single real-time system instead of email, phone and spreadsheets.

OVT continues at a pace set by each partner's operational priorities. The project ran in partnership with Canada's Ocean Supercluster through its Core Technology Leadership Program.

By Editor , 3 November 2026
Bridge to Life wins Health Canada license, FDA Breakthrough tag

Duluth, Georgia – November 03, 2026 -- Bridge to Life Ltd. has secured a Health Canada Medical Device License for its VitaSmart HOPE System and an FDA Breakthrough Device Designation for investigational use in donor intestines, widening the commercial reach of its organ perfusion platform in North America.

By Editor , 3 November 2026
Canadian Defence Firms Lobby Ottawa on Ownership, Procurement Rules

OTTAWA – November 03, 2026 -- Eighty-six percent of 49 Canadian defence and dual-use companies surveyed by the Alliance of Canadian Defence Companies (ACDC) said they would hire additional staff if future domestic defence demand were more certain. ACDC is using the finding to press federal officials and parliamentarians on procurement reform during a delegation to Parliament Hill.

By Editor , 3 November 2026

TORONTO – November 03, 2026 -- Blue Moon Metals (TSXV: MOON; NASDAQ: BMM) agreed to sell 100% of Blue Moon Norway AS to London-listed ACG Metals in an all-share transaction valued at US$220 million, shedding the construction-stage Nussir copper mine to refocus on its U.S. critical metals assets.

By Editor , 3 November 2026
Equinox Names Ex-Anheuser-Busch CEO Whitworth as Chief Executive

NEW YORK – November 03, 2026 -- Equinox appointed Brendan Whitworth, most recently CEO of Anheuser-Busch, as Chief Executive Officer, as a completed refinancing gives the luxury fitness operator more than $1 billion of capital planned for investment in its club portfolio, member experience and growth initiatives. Whitworth also joins the Equinox Board as a Director.